Familial exudative vitreoretinopathy (FEVR) is a rare inherited disorder of retinal angiogenesis. Cases can be autosomal dominant, autosomal recessive, or X-linked. FEVR patients have an avascular peripheral retina which, depending on the degree of ischaemia, causes the secondary complications of the disease. Expressivity may be asymmetric and is highly variable. Five genes have been identified that when mutated, cause FEVR; NDP (X-linked), FZD4 (autosomal dominant and recessive), LRP5 (autosomal dominant and recessive), TSPAN12 (autosomal dominant and recessive), and ZNF408 (autosomal dominant). Four of these genes have been shown to have a central role in Norrin/Frizzled4 signalling, suggesting a critical role for this pathway in retinal angiogenesis. In addition to the ocular features, LRP5 mutations can cause osteopenia and osteoporosis. All FEVR patients in whom molecular testing is not easily accessible should have dual energy X-ray absorptiometry (DEXA) scans to assess bone mineral density, as treatment can be initiated to reduce the risk of bone fractures.
Introduction
Familial exudative vitreoretinopathy (FEVR) was first described by Criswick and Schepens. 1 It is a rare disorder of retinal blood vessel development principally affecting retinal angiogenesis, leading to incomplete vascularisation of the peripheral retina and poor vascular differentiation. Cases can be inherited in an autosomal dominant, autosomal recessive, or X-linked manner, or can affect individuals with no family history. Most FEVR patients have an avascular peripheral retina but expressivity may be asymmetric and is highly variable, ranging from asymptomatic to severe within the same family. If there is a significant degree of retinal ischaemia, then secondary neovascularisation can occur leading to fibrosis, traction of the posterior pole structures, retinal detachment (RD), retinal folds, or complete retinal dysplasia in the most severe cases. A diagnosis of FEVR can be made if there is evidence of peripheral retinal avascularity in Z1 eye in patients of any age who were born at full term, or preterm with a disease tempo not consistent with retinopathy of prematurity (ROP).
Five genes have so far been identified that when mutated, cause FEVR; NDP (MIM 300658), FZD4 (MIM 604579), LRP5 (MIM 603506), TSPAN12 (MIM 613138), and ZNF408. [2] [3] [4] [5] [6] [7] Mutations in these genes account for around 50% of FEVR cases. 2, 3, 6, 8 Four of the genes identified to date have been shown to have a role in a variant of the Wnt signalling pathway, termed as Norrin/Frizzled4 signalling, 9 suggesting a crucial role for this pathway in retinal vascular development.
FEVR: a disorder of retinal angiogenesis

Vasculogenesis vs angiogenesis
Vascularisation of the retina begins at around 18 weeks gestation (WG) and is complete by 38-40 WG. The vessels are organised into a network of vascular plexuses, which form by a combination of vasculogenesis and angiogenesis. 10 Vasculogenesis is the process of vessel development de novo from endothelial precursor cells that coalesce into cords and then form a lumen. In angiogenesis, blood vessels form by sprouting from pre-existing vessels. Although not proven, it is believed that vasculogenesis forms most of the primary retinal vascular plexus of the developing human retina, while angiogenesis forms the remaining capillary layers around the fovea and in the deeper and peripheral retina. 10 
Formation of the vascular layers in the retina
Spindle-shaped mesodermal vascular precursor cells first enter the developing retina from the optic disc at around 15 WG. 10 These precursor cells aggregate to form solid cords, which subsequently become patent to form early retinal vessels. This event is preceded by the entry of neural ectodermal astrocytes into the retina from the optic nerve head, which then migrate across the retinal surface towards the periphery to provide a framework for growth of the primary (inner) vascular plexus. 10 At this stage in retinal development astrocytes have a critical role in vessel patterning and guidance. They respond to hypoxia in the developing retina by releasing VEGF-A, which promotes endothelial cell growth and differentiation. [11] [12] [13] Angiogenic sprouts made up of specialised endothelial cells are guided by varying concentrations of VEGF-A in the extracellular matrix. 14 Astrocytes also provide the structural framework for blood vessel growth and release factors that increase the integrity of the blood retinal barrier. 15 The primary vascular plexus forms at the interface between the nerve fibre layer (NFL) and the ganglion cell layer (GCL) and is complete by 25-26 WG. 16 The perifoveal and peripheral vasculature are not formed at this time. 10 At 25-26 WG, angiogenic sprouting into the retina from the primary retinal plexus, in response to extracellular VEGF-A, leads to the formation of the deeper retinal plexuses; and unlike the primary plexus these vessels develop independently of astrocytes. 10, 16, 17 The vessels migrate into the retina along Mü ller cell processes then turn perpendicularly to form two further parallel layers at the inner and outer borders of the inner nuclear layer (INL) in the macula. 17 In the midperipheral retina, only one further plexus grows at the outer border of the INL; and towards the far periphery, where the retina is thinner, the two vascular layers become less distinct and eventually form one layer ( Figure 1 ). [18] [19] [20] A fourth capillary layer is present within the thick NFL around the optic disc and along the temporal vascular arcades. These peripapillary capillaries run radially, in parallel with the retinal nerve fibres, and have few anastamoses. 18 Throughout retinal vascular development the immature vascular tree undergoes extensive pruning and remodelling. Both endothelial cell migration and leukocyte-mediated apoptosis take place to fashion the vasculature into an ordered pattern of different sized arteries, capillaries, and veins. 21, 22 Pericytes (sometimes referred to as mural cells) are embedded in the basement membrane of the vascular endothelium. The interaction between pericytes and endothelial cells is critical for the maturation and maintenance of the microvasculature in the retina. 23 The deeper retinal vessels are thought to grow along Mü ller cell processes into the retina but do not rely on VEGF-A released from Mü ller cells or astrocytes to develop. 24 These vessels may be guided by VEGF-A released from pre-existing vascular endothelial cells. 25 Interestingly, the knockout mouse models of four of the known FEVR genes (Ndp À / À , Fzd4 À / À , Lrp5 À / À , and Tspan12 À / À ) all show the absence of the deeper retinal plexuses in the presence of a formed primary retinal plexus (Figure 2 ). [26] [27] [28] [29] At present, there is no clinical data that demonstrate disturbance of the deeper retinal vascular layers in patients with FEVR. However, most patients with FEVR have a peripheral avascular retina and in mild cases the primary (inner) vascular layer appears to be normal. This suggests that FEVR may be a disorder of angiogenesis in which the primary vascular plexus develops normally but the secondary capillary layers in the deep and peripheral retina are absent or abnormal. This avascularity then causes the clinical features of the disease. This has not been described in patients as yet, perhaps because patients who present with visually significant FEVR invariably have distortion of the macular anatomy. Nevertheless, the murine models of FEVR support this hypothesis.
The hyaloid vasculature
Before blood vessels enter the retina the developing eye is supported metabolically by the hyaloid vasculature. This is a network of arterial vessels that branch off from the central hyaloid artery into the vitreous, around the developing lens and drain into the choroidal veins. 30 The hyaloid vasculature begins to regress at 13 WG and is completely gone by 40 WG when development of the retinal vasculature is complete. 31 Failure of the hyaloid vasculature to regress causes a range of pathology from non-sight threatening conditions (Bergmeister's papillae) to blindness (persistent fetal vasculature (PFV)) and can be a feature of FEVR. [32] [33] [34] [35] Phenotypic characteristics in FEVR
Clinical features
The hallmark of FEVR is peripheral retinal avascularity, which often has a V-shaped pattern in the temporal periphery. 36, 37 In mild cases, these peripheral retinal changes do not cause any symptoms. 38 In moderate to severe cases, pre-retinal neovascularisation and fibrosis at the junction between vascular and avascular retina can occur that causes traction of the macula and retinal vessels ( Figure 3 ). This can cause varying degrees of macular ectopia and visual dysfunction. In severe cases, the traction can lead to RD and retinal folds resulting in very poor vision. Patients can present at any age depending on the severity of the disease. An important clinical feature in FEVR is the lack of prematurity. The vitreoretinal signs seen in ROP are almost identical to those seen in FEVR. 39 RDs are a common finding in FEVR and occur in 21-64% of affected individuals. [36] [37] [38] 40, 41 They can be rhegmatogenous, tractional, or serous in nature. Advanced tractional RDs can progress to form radial folds in the retina, sometimes described as 'falciform'. These folds represent one of the classic features of severe FEVR (Figure 4 ), 42 and are similar to the fundal appearance seen in Norrie disease and osteoporosis pseudoglioma (OPPG). Often patients can have very mild or no disease in one eye, with severe disease in the fellow eye, and disease asymmetry is another common feature in FEVR. 40, 41 Less common findings are retinal exudation, secondary epiretinal membrane formation ( Figure 5 ), peripheral retinoschisis, neovascularisation, vitreous haemorrhage, secondary glaucoma (neovascular or phacomorphic), phacolytic uveitis, retinal capillary angioma, retained hyaloid vascular remnants, and PFV. 33, [36] [37] [38] 40, 41, 43, 44 The fundus fluorescein angiography (FFA) features in FEVR were published by Canny and Oliver. 45 In the current clinical management of the disorder this test is only used when the diagnosis is in doubt in very mild cases.
FEVR patients with LRP5 mutations have reduced bone mass, and those with severe NDP mutations are more likely to have progressive deafness and mental retardation. The spectrum of allelic FEVR disorders and the genotype-phenotype correlation in FEVR are [18] [19] [20] IPL, inner plexiform layer; OPL, outer plexiform layer; ONL, outer nuclear layer; PRL, photoreceptor layer; RPE, retinal pigment epithelium. discussed later in this review. Extra-ocular associations in FEVR are otherwise extremely rare. Nevertheless, both DiGeorge syndrome and congenital microcephaly have been described. 46, 47 
Phenotypic variability
In FEVR, there can be a range of disease severity in the individual, and within families. First-degree relatives of patients with severe FEVR often have mild asymptomatic disease despite having the same FEVR mutation. 48 This could be explained by the presence of genetic modifiers, which may have a protective or predisposing effect. Environmental influences, either systemic or local, could also have a role in the aetiology. In ROP, abnormally high and variable arterial oxygen levels (PaO 2 ) in premature infants have a profound effect on retinal vascular development. 49 FEVR patients are not premature and are not subjected to the extremely abnormal physiological conditions that premature infants are, but smaller changes in the intrauterine environment, like PaO 2 or exposure to certain drugs, may have greater influence in patients carrying FEVR mutations. Another common feature of FEVR is disease asymmetry. This asymmetry can be marked with some patients having an RD in one eye and no observable signs of disease in the other. These findings could suggest a local environmental difference between the two eyes during ocular development or, more plausibly, a somatic genetic variant in one eye having an influence on retinal vascular embryogenesis.
Staging
There have been three different grading systems devised in an attempt to classify FEVR. Laqua proposed a threestage system that was modified from one of the earliest descriptions of FEVR by Gow and Oliver. 50, 51 In stage 1, the patient is asymptomatic and all the pathology is confined to the peripheral retina. Stage 2 describes a peripheral fibrovascular mass with dragging of the posterior pole structures causing reduced visual acuity. In stage 3, complications that cause severe visual loss are Miyakubo et al 37 suggested a slightly more complicated five-stage system ranging from type 1 (peripheral avascularity of less than two disc diameters with straightening of the temporal retinal vessels) to type 5 (cicatricial mass in the periphery). More recently, Pendergast et al 52 proposed the most comprehensive system described to date (Table 2 ). FEVR occurs due to a congential failure of retinal vascular development and the disease rarely progresses. Therefore, these staging systems do not represent stages through which the disease advances.
Genetics and molecular mechanisms for pathogenicity
Genes FZD4 FEVR was first described by Criswick and Schepens 1 in two families; one with an autosomal dominant inheritance pattern and one which suggested X-linked recessive inheritance. The EVR1 locus was initially mapped to the chromosomal region 11q13-q23 by Li et al 53 using traditional genetic linkage studies in two families with autosomal dominant FEVR. This region was later refined to 1.55 Mb by Robitaille et al 4 who then went on to discover mutations in FZD4 in two autosomal dominant pedigrees. Since the first disease causing FZD4 mutations were identified, several different mutations have been described in autosomal dominant pedigrees and more recently it has been shown that FZD4 mutations can also cause recessive FEVR. 5, 35, 48, 54, 55 Kaykas et al 56 demonstrated that oligomerisation of mutant and wildtype FZD4 in the endoplasmic reticulum reduces FZD4 function by preventing sufficient wild-type protein from reaching the cell membrane. This dominant-negative effect may be the pathological mechanism causing the disease phenotype in patients with heterozygous FZD4 mutations. Alternatively, nonsense-mediated decay and subsequent haploinsufficiency of the protein may have a role. Missense mutations predicted to disrupt the expressed protein in the extracellular cysteine-rich domain (CRD), intracellular loops 1 and 3, the transmembrane and the cytoplasmic domains cause FEVR. This suggests that these protein domains have a significant role in FZD4 protein function. NDP In the 1920s Leopold Heine and Gordon Norrie described 'congenital pseudotumours' of the retina in two large families with an X-linked recessive inheritance pattern. 57 Warburg 58 later described progressive deafness and mental retardation associated with the disorder and named the syndrome Norrie disease. Genetic linkage to chromosome Xp11.4 was noted by Warburg and others and defined as EVR2. The gene involved, NDP, was finally identified in 1992 by positional cloning. [59] [60] [61] [62] The protein encoded by the NDP gene was subsequently named Norrin. Fullwood et al 63 studied a family with X-linked FEVR and found a suggestion of linkage to the Xp11 region. They proposed the hypothesis that Norrie disease and X-linked FEVR could be allelic, and this was later validated when mutations were identified in NDP in X-linked FEVR families. 7 Mutations in the NDP gene cause Norrie disease and X-linked FEVR. 7, 64 In addition, NDP mutations have been identified in PFV, Coats disease, and ROP. 32, 65, 66 The majority of known mutations in NDP involve its cysteine knot domain. The cysteine knot domain binds to the CRD of FZD4 to initiate intracellular signalling so it is not surprising that mutations in this domain cause disease. Several missense mutations are predicted to change one of the highly conserved cysteine residues within this domain. This highlights the importance of the cysteine knot domain to the function of Norrin in humans.
LRP5
Toomes and co-workers failed to identify an FZD4 mutation in an Asian family with autosomal Eye dominant FEVR, which had previously been mapped to the EVR1 locus described by Li et al. 53, 67, 68 Genotyping in this family around the FZD4 gene revealed that the mutation in this family lay in an B15-cM region 10 cM centromeric to FZD4, providing evidence for a separate locus termed EVR4. 67 70 now known to be on the same disease spectrum as FEVR. The first LRP5 mutations found to cause FEVR were identified in 2004, and since then many mutations have been described in both autosomal dominant and recessive pedigrees. 5, 54, 69 When these patients are tested by bone dual energy X-ray absorptiometry (DEXA) scanning they are found to have reduced bone density. 54 Some LRP5 polymorphisms have also been found to be associated with idiopathic osteoporosis. 71, 72 Hartikka et al 73 found heterozygous LRP5 mutations in three children with osteoporosis but did not detect an eye phenotype. As discussed earlier, FEVR patients are often asymptomatic so these patients may well have had undiagnosed FEVR. In addition, dominant missense mutations have been reported in patients with disorders characterised by high bone mass. 74 The bone mass phenotype was recently investigated by Yadav et al. 75 This group demonstrated that LRP5, in addition to its importance in retinal vascular development, has a separate role in duodenal enterochromaffin cells from where it controls osteoblast function and bone formation by inhibiting serotonin synthesis.
The range of types and locations of known LRP5 mutations suggest that no functional protein is present in the OPPG patients. FEVR is predominately caused by heterozygous mutations, though some recessive LRP5 mutations have been described. Missense mutations involving the four extracellular YWTD-EGF domains make up the majority of all known LRP5 missense mutations, highlighting this region of the protein as functionally important in humans.
TSPAN12
In 2010, TSPAN12 mutations causing FEVR were identified by two different groups. 3 Mutations can be truncating, missense, or splice site in nature and there is no strong correlation between the severity of disease and type or location of mutation. Poulter et al 6 described this lack of genotype-phenotype correlation in patients with different TSPAN12 mutations and suggested that haploinsufficiency of TSPAN12 is the likely cause of FEVR in these patients.
ZNF408
The most recent gene to be implicated in the pathogenesis of FEVR is ZNF408. Collin et al 2 discovered disease causing mutations in three families with autosomal dominant FEVR. The group went on to carry out functional experiments to further establish the validity of their findings. These included immunolocalisation studies which demonstrated that protein expressed from mutated ZNF408 behaves abnormally in monkey cells, and a zebrafish model of retinal vascularisation that showed abnormal vascular differentiation when znf408 is absent. The immunolocalisation studies suggested that one of the missense mutations acted in a dominant-negative way and the group concluded that this may be the molecular mechanism causing the disease phenotype. 2 
Norrin/Frizzled4 signalling
The first four FEVR genes identified all encode proteins that function in Norrin/Frizzled4 signalling. This pathway is a unique variant of Wnt signalling and has a central role in retinal vascular development. 9 Wnt signalling is involved in multiple developmental events during embryogenesis and has a role in cell proliferation and regulation in adult tissues, including cancer. 77, 78 When mutations in FZD4 and LRP5 were identified in FEVR patients, the function of the corresponding proteins as co-receptors in Wnt signalling was already 
Genetically related disorders
Norrie disease
Norrie disease is a severe X-linked retinal dysplasia with non-existent or near non-existent vision at birth caused by mutations in the NDP gene. 79 About 30-50% of Norrie disease patients have developmental delay and most have progressive hearing loss from early childhood. Female cases have been reported but are extremely rare. 80 The classic ocular feature of Norrie disease is a glistening white elevated mass seen through a clear lens, historically referred to as a pseudotumour or pseudoglioma. These are non-specific terms and refer to anything that looks similar to a tumour in the retina. As with severe FEVR the disease can involve the anterior segment structures and cause secondary complications. 79 The posterior disease is not treatable, but management of the secondary complications is indicated to prevent loss of the globe.
Osteoporosis pseudoglioma
OPPG is characterised by osteoporosis and ocular features similar to severe FEVR, and in the majority of cases is caused by mutations in the LRP5 gene. 71 While the majority of OPPG patients are congenitally blind with a severe bilateral retinal dysplasia similar to that seen in Norrie disease, some have less severe ocular findings more common in FEVR. 71 Markedly reduced bone mineral density means that affected individuals often suffer from childhood fractures secondary to relatively mild trauma. Growth retardation, muscle hypotonia, and developmental delay may also be present. The bone disease is managed with bisphosphonate treatment and eye complications are treated in a similar manner to FEVR and Norrie disease. 72 
Spectrum of FEVR-related retinopathies
Both Norrie disease and OPPG were given names and classifications before the pathogenic gene mutations were discovered. It is now clear that these diseases are part of the same disease spectrum as FEVR. Patients at the severe end of the spectrum are more likely to have the extra-ocular features described above which aid the clinician in making the diagnosis of either Norrie disease, if mental retardation and deafness are present, or OPPG, if childhood fractures or reduced bone density are an associated feature.
Genotype-phenotype correlations
There is no genotype-phenotype correlation for the ocular features observed in FEVR. Mutations in FZD4, NDP, LRP5, TSPAN12, and ZNF408 can cause varying degrees of disease severity within the same family and between eyes of the same individual. 2, 5, 40, 48, 81 If a patient has the low bone mass phenotype, then a dominant or recessive LRP5 mutation is the likely cause. No patients with FZD4, NDP, TSPAN12, or ZNF408 mutations have been reported to have reduced bone mass, but it is often the case that bone density scanning is not carried out. 54 However, given that the bone phenotype has been shown to be independent of the Norrin/Frizzled4 signalling pathway, a bone phenotype is not expected in these patients. 75 If a patient is male, has a severe ocular phenotype and hearing loss with or without developmental delay, then a mutation in the NDP gene is likely.
In FEVR, there does not appear to be a clear correlation between the severity of the mutation and the severity of the phenotype, with the exception that recessive mutations usually result in a more severe phenotype. Many severely affected patients have only been shown to harbour a single mutation in an FEVR gene. This raises the possibility that a second unidentified gene mutation and/or a combination of pathogenic polymorphisms in Eye genes important in retinal vascular development are present in these individuals.
Visual function and long-term visual outcomes
Most patients with FEVR retain good visual acuity with 64-74% of affected patients having vision of 6/12 or better. 36, 41 In a comprehensive review, Benson 38 estimated that around 50% of patients are asymptomatic.
Children and adolescents diagnosed with the disease have a poorer visual prognosis when compared with adults; with macular ectopia, RDs, and retinal folds being the main causes of reduced vision. Progression is uncommon in adults but has been described. 38, 41 Management It is generally agreed that only patients that show signs of significant progression, or are at high risk of progression, should be treated. 36, 38, 41 All FEVR patients in whom molecular testing is not easily accessible, adults or children, should have DEXA scans to assess bone mineral density. If positive, then the patient should be referred to a rheumatologist for bisphosphonate therapy. 72 Due to the low prevalence of the disease, there is an absence of robust data to guide clinicians in managing FEVR patients. Shukla et al 41 treated 17 patients (20 eyes) prophylactically with either laser or cryotherapy. The patients all had peripheral abnormalities that included retinal breaks, exudative RD, neovascularisation, and/or vitreous haemorrhage. The final visual acuity was stable in all patients at a mean follow-up of 16.4 months (range 2-40). In contrast, Pendergast and Trese 52 treated 15 eyes with retinal laser and 7 progressed to RD requiring surgical repair. In the same study, 32 eyes in total required RD surgery. Twenty-nine of these eyes were followed up over 6 months and eighteen (62%) had a successful surgical (anatomical) outcome with just over half gaining visual acuity. Ikeda et al 82 found an 86% reattachment rate in 28 FEVR eyes that needed surgery, with 71% gaining visual acuity. Published RD surgery outcomes are summarised in Table 3 . The surgery performed in these studies was an even mixture of pars plana vitrectomy, scleral buckling, or a combination of both. Poor surgical outcome is more common in patients under the age of 19. 36, 41, 52, 83, 84 The use of intravitreal anti-VEGF injections to reduce the exudative and neovascular components of FEVR and other inherited retinal vasculopathies has been reviewed. 85 Anti-VEGF therapy reduces retinal exudation and neovascularisation in FEVR patients but the rapid resolution of exudation can stimulate worsening vitreoretinal traction that often requires surgery. This treatment may have a role as an adjunctive therapy before surgery.
Vitreoretinopathies with similarities to FEVR
Coats disease
Coats disease is a sporadic retinal vasculopathy characterised by retinal telangiectasias, intraretinal exudation, and exudative RD that is not associated with any systemic disease. The disease is unilateral in 95% of cases, and mostly affects young males. 86 Patients usually present in early childhood, but cases can often go unnoticed due to the fellow eye being normal. 86 The exudation most commonly involves the macular region, and often spreads diffusely to the whole retina. If left untreated then the exudation can penetrate the external limiting membrane to cause an exudative RD, which eventually will slowly progress to a total RD and secondary neovascular glaucoma. Mild cases can be treated successfully with retinal laser or cryotherapy, but the prognosis deteriorates and intervention becomes less successful as the disease progresses. Advanced cases sometimes require enucleation. 87 The aetiology of Coats disease is not clear. The disease appears to spare the larger retinal vessels, so the disorder somehow disrupts the normal development of the smaller retinal vessels and capillaries. Black et al 65 described a family in which the mother of a Norrie disease patient had Coats disease and both patients carried a missense NDP mutation. They suggested that the cause of the unilateral disease in the mother may have been a second somatic mutation in the developing retina of the affected eye and postulated that a similar mechanism may contribute to Coats disease. Prompted by this finding the authors screened RNA extracted from the enucleated eyes of nine male Coats patients and found a somatic NDP mutation in the retinal tissue of one of these patients. 65 NDP is situated on the X chromosome and this theory could explain why the disease almost exclusively affects males.
Persistent fetal vasculature
PFV is a congenital disorder in which the hyaloid vasculature and primary vitreous have failed to regress. The disorder is normally sporadic, has no sex predilection, and is almost always unilateral. 88 Inherited forms of this disease have been reported, but are extremely rare. These familial cases are always bilateral and can be inherited in a recessive or dominant pattern. 89, 90 Some cases are mild and do not have significant ocular morbidity but most are severe resulting in secondary cataract and glaucoma. 88 Surgery is advocated only in selected cases with anterior PFV. 91 The phenotypic overlap of PFV and FEVR was highlighted by Robitaille et al 34 who showed that FZD4 mutations can cause features identical to PFV. The first gene mutation to directly be implicated in PFV was identified by Prasov et al 92 who found a homozygous ATOH7 mutation in a family with PFV. The close relationship of PFV and FEVR makes ATOH7 an excellent candidate gene for screening in FEVR. The cause of sporadic unilateral PFV is not known. It is interesting to speculate that patients with unilateral PFV may have undergone a somatic mutation in the affected eye during the early stages of ocular development. There is no experimental evidence to support this hypothesis at present, but a study of enucleated PFV eyes looking for somatic mutations in candidate genes, similar to the Coats disease study conducted by Black et al, 65 would be of interest.
Incontinentia pigmenti
Incontinentia pigmenti (IP) is an X-linked dominant disorder of the skin, which is associated with ocular features very similar to FEVR in about one-third of cases. 93 The disease is a form of ectodermal dysplasia and may also cause abnormalities of the teeth, nails, hair (alopecia), and neurological system (developmental delay and epilepsy). In the majority of cases a vesicular rash is present at birth, predominately on the extremities and the trunk, which then becomes verrucous in the first few months of life. The skin subsequently develops hyperpigmented lesions, which slowly become hypopigmented over a period of several years. The disorder is normally lethal prenatally in males and in surviving females there is significant phenotypic variability. Patients can have any of the features with varying degrees of severity.
The majority of cases are caused by mutations in the IKBKG gene on chromosome Xq28. 94 IKBKG encodes a protein (NEMO) that forms a regulatory subunit of the IkB kinase complex, which is required for the activation of the transcription factor NF-kB. 95 NF-kB has an important role in many inflammatory, immune, and apoptotic pathways. 96 Cells expressing the mutated X chromosome have reduced levels of NF-kB and are not able to prevent apoptosis in the presence of inflammatory cytokines. The variable expressivity of the disorder is thought to be due to skewed X inactivation.
Retinopathy of prematurity
Although environmental factors represent the major determinant in the pathogenesis of ROP, there is increasing evidence that the genetic background of the individual may also have a role. 97 FEVR genes are excellent candidates for screening in ROP due to the phenotypic similarities between the disorders. NDP, FZD4, and LRP5 genetic variants have all been identified in patients with ROP. 98, [99] [100] [101] These findings suggest that FEVR genes may be implicated in ROP disease; however, several small gene association studies have been carried out which have not supported this hypothesis. [102] [103] [104] [105] Further larger studies are required before any definitive conclusions can be made regarding the association of specific genetic variants and severity of ROP.
Conclusions
Mutations in NDP, FZD4, LRP5, TSPAN12, and ZN408 account for B50% cases of FEVR. 2, 3, 6, 8 It is clear that there are still a large proportion of FEVR patients in whom the pathogenic genetic variants remain unidentified and therefore there is huge potential for novel scientific discovery within this field. Four of the known FEVR genes encode proteins known to have a major role in Norrin/Frizzled4 signalling, a variant of Wnt signalling. There are several Wnt signalling pathways, and each pathway is turned on in a highly specific manner. The Norrin/Frizzled4 pathway has a specialised function in helping to build small blood vessels in the developing retina. The detection of more novel FEVR genes may either help to further characterise this pathway, or uncover a completely new molecular pathway. 
Eye
There is increasing evidence, from both human and animal studies, that Wnt signalling has an important role in the pathogenesis of diabetic retinopathy. 106, 107 It is thought that Wnt signalling becomes aberrantly upregulated due to oxidative stress, and several groups have investigated whether blocking this pathway could have a therapeutic benefit. Both Lee et al and Liu et al have recently published experiments using the mouse oxygen-induced retinopathy model in which they showed that antagonising Wnt signalling reduces retinal vascular leakage, inflammation, and ischaemia. [106] [107] [108] [109] Current treatments for diabetic retinopathy are aimed at reducing sight loss after the sightthreatening pathology has developed. These findings demonstrate the potential for a drug to be developed that prevents the ischaemic and exudative complications of diabetic retinopathy by inhibiting the Wnt pathway. The highly specific function of Norrin/Frizzled4 signalling in the eye makes this variant of Wnt signalling a very attractive target for drug development.
FEVR is a clinically and genetically heterogeneous disorder affecting the development of the retinal vasculature. Though it is a rare disease, studying families with FEVR is of considerable clinical and scientific interest as each new FEVR gene that is identified increases our understanding of the molecular mechanisms controlling angiogenesis in the retina. In diseases such as diabetic retinopathy and ROP, pathological angiogenesis driven by retinal ischaemia is the principal pathology. The study of FEVR may therefore support the development of therapies that control or prevent the sight-threatening complications of these far more common diseases.
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